Skip to main content
Clinical Trials/NL-OMON34646
NL-OMON34646
Completed
Not Applicable

Clinical and microbiological evaluation of different implant surface decontaminating procedures in the surgical treatment of peri-implantitis; a double blind placebo controlled randomized clinical study - Implant surface decontamination in peri-implantitis treatment

niversitair Medisch Centrum Groningen0 sites60 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
infection of the gingiva surrounding a dental implant
Sponsor
niversitair Medisch Centrum Groningen
Enrollment
60
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\) The patient is \>\= 18 years of age;
  • 2\) The patient has at least one endosseous implant in the oral cavity with clinical and radiographical signs of peri\-implantitis. Peri\-implantitis is defined as a loss of marginal bone \>\= 2 mm as compared to a fixed reference point on the dental implant, in combination with bleeding and/or suppuration on probing and a peri\-implant probing depth \>\= 5 mm;
  • 3\) The implants have been exposed to the oral environment for at least two years;
  • 4\) The patient is capable of understanding and giving informed consent.

Exclusion Criteria

  • 1\) Medical and general contraindications for the surgical procedures;
  • 2\) A history of local radiotherapy to the head and neck region;
  • 3\) Pregnancy and lactation;
  • 4\) Diabetes;
  • 5\) Systemic use of antibiotics during the last 2 months;
  • 6\) Long\-term use of anti\-inflammatory drugs;
  • 7\) Incapability of performing basal oral hygiene measures as a result of physical or mental disorders;
  • 8\) Active, uncontrolled periodontal pathology of the remaining dentition;
  • 9\) Local use of antibiotics or use of other anti\-septic / antimicrobial therapies in the oral cavity during the last 2 months;
  • 10\) Bruxism;

Outcomes

Primary Outcomes

Not specified

Similar Trials